This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)
C3_TONGUENAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
750 |
4. Check minimum number of eventsNone |
750 |
5. Include endpointsNone |
750 |
6. Filter based on genotype QC (FinnGen only) |
750 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 750 | 313 | 437 |
| Unadjusted period prevalence (%) | 0.16 | 0.11 | 0.19 |
| Median age at first event (years) | 63.32 | 62.53 | 63.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 447
- Matched controls
- 4470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
323.0
374
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
243.6
315.1
297
36
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
251.6
217
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
1028.2
243.7
217
*
130
Kela drug reimbursment
Malignant tumour
+∞
198.1
175
*
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
162.7
146
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
156.7
141
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
133.2
121
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
150.3
126.0
129
12
GBB00
NOMESCO Finland
Tracheostomy
123.2
119.5
125
14
JDB10
NOMESCO Finland
Percutaneous gastrostomy
102.6
107.4
115
15
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
105.5
97
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
9.2
98.0
276
667
WF003
NOMESCO Finland
Adjuvant radiotherapy
1152.3
97.9
92
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
103.7
97.1
104
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
25.6
91.9
132
72
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
80.0
85.6
95
15
PJA12
NOMESCO Finland
Sentinel node biopsy
968.9
84.4
80
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
84.1
78
*
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
+∞
77.4
72
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
44.8
75.7
93
26
K13.29
ICD-10 Finland
Indefinite leukoplakia
84.5
75.3
83
12
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
39.6
72.9
92
29
SAA03
NOMESCO Finland
Extended examination of mouth
6.2
69.7
292
1047
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
23.4
67.0
98
53
WX408
NOMESCO Finland
General anesthesy, balanced
6.4
66.1
225
609
N02AA05
ATC
oxycodone; systemic
8.9
65.0
156
254
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
17.0
63.2
104
78
WF002
NOMESCO Finland
Radical radiotherapy
688.3
62.4
60
*
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
+∞
60.8
57
*
A07AA02
ATC
nystatin; oral
11.3
56.3
113
130
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
212.8
55.3
56
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
14.6
52.7
92
78
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
52.1
49
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
119.9
50.0
53
5
H02AB02
ATC
dexamethasone; systemic
51.1
48.6
58
13
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
47.8
45
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
28.0
47.4
65
27
XX3DW
NOMESCO Finland
Time consuming IT work
11.0
47.3
95
107
EBA15
NOMESCO Finland
Extraction of large number of teeth
13.0
46.5
85
79
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.6
46.1
134
272
A04AA02
ATC
granisetron; systemic, transdermal
255.7
45.9
46
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
255.7
45.9
46
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
44.8
129
258
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
43.4
41
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
231.1
41.6
42
*
SXA10
NOMESCO Finland
Epithel biopsy of mouth
39.0
41.4
52
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
41.3
39
*
Z51.5
ICD-10 Finland
Palliative care
28.3
40.4
55
22
R4190
NOMESCO Finland
Nutritional therapy
20.6
38.7
58
32
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
38.1
36
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
37.0
35
*
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
37.0
35
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
37.0
35
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
17.6
35.4
56
36
WX402
NOMESCO Finland
General anaesthesia
5.1
34.9
126
321
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.5
34.4
250
1188
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
33.8
32
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
33.8
32
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
351.7
33.4
33
*
EBA10
NOMESCO Finland
Surgical removal of tooth
5.7
30.9
96
203
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
30.6
29
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
48.8
30.1
36
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
29.4
129
392
K13.20
ICD-10 Finland
Idiopathic leukoplakia
31.8
29.0
38
13
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
160.4
29.0
30
*
ZZA00
NOMESCO Finland
Split skin graft
17.0
28.8
46
30
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
28.4
27
*
SBB10
NOMESCO Finland
Teeth copy
8.6
28.0
63
84
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
28.0
251
1315
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
27.4
26
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
287.5
27.0
27
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
49.0
26.8
32
7
ECA20
NOMESCO Finland
Biopsy of gingiva
49.0
26.8
32
7
SXC03
NOMESCO Finland
Other oral or dental procedure
27.8
26.6
36
14
EKA10
NOMESCO Finland
Biopsy of cheek
13.7
26.5
46
37
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
26.3
25
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
26.3
25
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.7
26.2
63
93
WX110
NOMESCO Finland
Local anesthesy
3.1
25.3
337
2227
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
25.2
24
*
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
264.2
24.9
25
*
EBB10
NOMESCO Finland
Insertion of dental implant
20.0
24.8
37
20
ZXC10
NOMESCO Finland
Use of laser
17.9
24.5
38
23
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
91.9
23.9
26
*
WZC30
NOMESCO Finland
Teaching
4.8
23.6
85
209
K14.9
ICD-10 Finland
Disease of tongue, unspecified
57.3
23.3
27
5
D20
ICPC
Mouth/tongue/lip symptom/complaint
8.2
23.2
53
72
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
+∞
23.1
22
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.1
22
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
23.1
22
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
23.1
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
126.5
22.8
24
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
34.3
22.7
29
9
R4110
NOMESCO Finland
Physiotherapy
3.0
21.9
155
665
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
84.5
21.9
24
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.3
21.8
54
83
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
21.0
20
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.7
20.9
63
126
A01AB09
ATC
miconazole; local oral
4.6
20.8
78
198
SBA00
NOMESCO Finland
Microbiological examinations
11.1
20.6
39
38
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
60.4
20.1
23
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.5
19.9
53
90
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
+∞
19.9
19
*
8070/3-C02.2
ICD-O-3
Squamous cell carcinoma, NOS, of ventral surface of tongue, NOS
+∞
19.9
19
*
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
17.4
19.9
31
19
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.8
19.8
156
708
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
19.5
73
185
R13
ICD-10 Finland
Dysphagia
5.4
19.2
60
125
SAA02
NOMESCO Finland
Basic examination of mouth
2.5
19.1
299
1981
R4130
NOMESCO Finland
Speech therapy
11.8
19.1
35
32
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
18.9
18
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.4
18.5
31
23
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
7.6
18.1
43
62
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
17.8
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.8
17
*
4392
FHL
Tongue and / or Mouth resection or excision
+∞
17.8
17
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
99.0
17.7
19
*
B37.08
ICD-10 Finland
Other candidal stomatitis
52.2
17.1
20
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
36.6
16.8
21
6
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
16.8
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.8
16
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
16.8
16
*
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
93.6
16.7
18
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
41.8
16.5
20
5
T05
ICPC
Feeding problem of adult
31.4
16.2
21
7
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
62.3
15.9
18
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
15.7
15
*
1412A
ICD-9 Finland
Malignant neoplasm of tongue, Tip and lateral border of tongue
+∞
15.7
15
*
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
+∞
15.7
15
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
15.7
15
*
A04AD12
ATC
aprepitant; systemic
+∞
15.7
15
*
A04AA01
ATC
ondansetron; systemic, rectal
11.4
15.7
29
27
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
88.2
15.7
17
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.8
15.6
45
85
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
15.5
15.5
25
17
J02AC01
ATC
fluconazole; systemic
2.4
15.4
180
989
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.6
15.3
33
41
K11.70
ICD-10 Finland
Hypoptyalism
33.0
14.9
19
6
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
+∞
14.7
14
*
EBA00
NOMESCO Finland
Extraction of tooth
2.3
14.7
172
942
A06AD11
ATC
lactulose; oral
3.1
14.4
86
319
SXC05
NOMESCO Finland
Other oral or dental procedure
5.1
14.3
46
99
EKB00
NOMESCO Finland
Excision of lesion of cheek
44.0
14.2
17
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
3.9
14.1
61
176
K08.3
ICD-10 Finland
Retained dental root
4.2
14.0
54
140
ED1AA
NOMESCO Finland
Mandipular X-ray examination
31.2
14.0
18
6
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.7
13.8
40
76
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
13.8
101
423
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.7
13.8
47
108
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
+∞
13.6
13
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
13.6
13
*
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
35.2
13.6
17
5
K12.10
ICD-10 Finland
Stomatitis NOS
35.2
13.6
17
5
JN4BD
NOMESCO Finland
Extensive body CT
5.1
13.6
43
91
Z50.5
ICD-10 Finland
Speech therapy
22.0
13.4
19
9
L43.8
ICD-10 Finland
Other lichen planus
11.0
13.4
25
24
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
13.5
13.1
22
17
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
72.0
12.7
14
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
72.0
12.7
14
*
4707
FHL
Dissection Colli radicalis
+∞
12.6
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
12.6
12
*
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
+∞
12.6
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
12.6
12
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
13.7
12.6
21
16
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
14.9
12.4
20
14
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
38.7
12.3
15
*
D83
ICPC
Mouth/tongue/lip disease
27.6
12.1
16
6
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
7.9
12.1
27
36
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
12.1
35
67
UJC01
NOMESCO Finland
Scopy of lower throat
15.2
11.9
19
13
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
13.0
11.7
20
16
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
19.6
11.7
17
9
116
Kela drug reimbursment
Prostate cancer
+∞
11.5
11
*
EJB50
NOMESCO Finland
Total glossectomy
+∞
11.5
11
*
EJB70
NOMESCO Finland
Extensive partial excision of floor of mouth and tongue
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
C02.3
ICD-10 Finland
Malignant neoplasm: Anterior two-thirds of tongue, part unspecified
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
123.1
11.5
12
*
WW500
NOMESCO Finland
Blood transfusion
8.7
11.4
24
29
K14.61
ICD-10 Finland
Glossodynia
12.3
11.4
20
17
SPF30
NOMESCO Finland
Soling for prothesis
6.7
11.3
28
44
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
20.7
11.2
16
8
K05.31
ICD-10 Finland
Periodontitis pronounced
3.0
10.8
65
240
EB1WA
NOMESCO Finland
NA
22.1
10.7
15
7
SPF20
NOMESCO Finland
Temporary soling for filling
13.3
10.7
18
14
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
61.5
10.7
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
10.5
45
129
EJC30
NOMESCO Finland
Reconstruction of tongue
+∞
10.5
10
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
10.5
10
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
10.5
10
*
JDB00
NOMESCO Finland
Gastrostomy
+∞
10.5
10
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
10.5
10
*
N02BE01
ATC
paracetamol; systemic, rectal
2.3
10.4
381
3187
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.4
10.4
51
163
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.4
197
1276
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
33.4
10.4
13
*
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
10.2
303
2311
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
11.7
10.1
18
16
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
41.0
10.0
12
*
WX002
NOMESCO Finland
Sedation and analgesia
2.3
10.0
107
545
K02.1
ICD-10 Finland
Caries of dentine
1.9
9.9
243
1722
L43.9
ICD-10 Finland
Lichen planus, unspecified
6.8
9.9
24
37
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
18.0
9.5
14
8
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
30.7
9.4
12
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
9.4
9
*
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
9.4
9
*
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
EJB60
NOMESCO Finland
Partial excision of floor of mouth
+∞
9.4
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.3
121
668
WX872
NOMESCO Finland
Intensive care
4.0
9.3
36
95
ZXA05
NOMESCO Finland
Left side
2.1
9.2
127
719
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
11.8
9.1
16
14
ECB20
NOMESCO Finland
Oral alveoplasty
11.8
9.1
16
14
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.4
9.1
32
77
ENA10
NOMESCO Finland
Biopsy of pharynx
37.5
9.1
11
*
K05.30
ICD-10 Finland
Periodontitis complex
2.5
8.9
71
309
JN4AD
NOMESCO Finland
Body CT examination
4.9
8.9
28
60
S18
ICPC
Laceration/cut
1.9
8.8
191
1277
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
8.8
46
155
A01AB04
ATC
amphotericin B; local oral
3.6
8.8
39
116
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
5.7
8.7
24
44
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
8.7
36
101
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
16.7
8.6
13
8
ZZR00
NOMESCO Finland
Flap of skin
16.7
8.6
13
8
WX707
NOMESCO Finland
Fiberoscopic intubation
28.1
8.5
11
*
SPD01
NOMESCO Finland
Mucosa-supported complete denture
28.1
8.5
11
*
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
6.9
8.5
20
30
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
91.7
8.4
9
*
EJ2S1
NOMESCO Finland
Photography of oral mucosa
91.7
8.4
9
*
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
91.7
8.4
9
*
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
91.7
8.4
9
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
6.0
8.4
22
38
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
8.4
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
8.4
8
*
4394
FHL
Glossectomy or hemiglossectomy
+∞
8.4
8
*
ECA30
NOMESCO Finland
Excision of lesion of gingiva
11.0
8.3
15
14
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.8
8.2
18
24
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
8.2
47
168
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.1
97
515
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
34.0
8.1
10
*
H03AA01
ATC
levothyroxine sodium; systemic
2.1
8.0
105
577
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
8.7
7.9
16
19
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
7.8
45
162
WX730
NOMESCO Finland
Conventional respirator
7.6
7.7
17
23
D70.82
ICD-10 Finland
Drug-induced neutropenia
45.8
7.7
9
*
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
45.8
7.7
9
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
7.7
40
135
Z43.1
ICD-10 Finland
Attention to gastrostomy
25.5
7.6
10
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.2
7.5
39
131
L02BA01
ATC
tamoxifen; oral
81.4
7.4
8
*
SCA03
NOMESCO Finland
Preventive oral health care, extensive
3.9
7.3
29
79
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
7.3
7
*
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
+∞
7.3
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
8071/3-C02.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of border of tongue
+∞
7.3
7
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
16.1
7.3
11
7
D07AD01
ATC
clobetasol; topical
2.2
7.3
73
358
A01AB10
ATC
natamycin; local oral
5.0
7.2
22
46
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.0
7.2
41
146
ZX120
NOMESCO Finland
Intravenous
3.0
7.2
41
146
SCB02
NOMESCO Finland
Training for mouth care at home
30.5
7.2
9
*
K14.09
ICD-10 Finland
Glossit UNS
30.5
7.2
9
*
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
30.5
7.2
9
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
7.2
114
673
S01.50
ICD-10 Finland
Open wound in oral cavity
12.3
7.1
12
10
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
5.1
7.1
21
43
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
7.0
155
1024
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.9
129
808
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.5
6.9
30
89
R02AD02
ATC
lidocaine; local oral
6.3
6.8
17
28
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
11.2
6.8
12
11
TQW99
NOMESCO Finland
Other minor procedure on skin
4.8
6.8
21
45
SPA48
NOMESCO Finland
Precision impression for denture, demanding
40.7
6.8
8
*
K14.88
ICD-10 Finland
Other diseases of tongue
40.7
6.8
8
*
B01AB05
ATC
enoxaparin; parenteral
1.8
6.8
122
754
SDA02
NOMESCO Finland
Parodonthologic therapy
1.8
6.7
139
896
RS316
NOMESCO Finland
NA
22.9
6.7
9
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
6.6
110
657
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.0
6.6
25
66
J01DB01
ATC
cefalexin; oral
1.8
6.6
347
2944
Z01.9
ICD-10 Finland
Special examination, unspecified
3.0
6.5
35
122
XF612
NOMESCO Finland
Measurement of central venous pressure
70.8
6.4
7
*
XQ902
NOMESCO Finland
Other photography
14.6
6.4
10
7
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
18.3
6.3
9
5
L02AE02
ATC
leuprorelin; implant, parenteral
18.3
6.3
9
5
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
SPC45
NOMESCO Finland
Preparation of third or later intermediate attachment tooth for bridge
+∞
6.3
6
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
+∞
6.3
6
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
6.3
6
*
C02
ICD-10 Finland
Malignant neoplasm of other and unspecified parts of tongue
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
6.3
6
*
C02.4
ICD-10 Finland
Malignant neoplasm: Lingual tonsil
+∞
6.3
6
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
SPA52
NOMESCO Finland
Determination of bite and dental arch location, very demanding
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
RD210
NOMESCO Finland
NA
6.4
6.2
15
24
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
6.2
49
213
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
6.2
54
247
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.7
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
224
182
17.12
238.60
1.5
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
293
459
9.83
194.71
2.1
2.0
g/l
0.2
0.2
5.76
284
415
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
93
15
70.63
170.07
4.1
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
475
1720
5.80
124.78
4.1
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
296
834
5.21
101.55
5.2
2.8
mmol/l
0.8
0.8
15.49
276
767
(3002256) Pathology report gross observation
194
406
6.10
92.60
1.5
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
81
65
13.85
84.19
2.0
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
202
505
5.11
77.92
5.2
6.2
mmol/l
6.0
9.9
17.74
194
476
(3003458) Phosphate [Moles/volume] in Serum or Plasma
251
747
4.55
77.83
6.2
4.5
mmol/l
1.0
1.0
2.10
240
675
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
84
81
11.55
77.62
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
379
1627
3.69
67.92
3.1
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
326
1269
3.78
67.88
2.9
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
472
2436
3.53
61.19
4.8
3.7
g/l
35.0
35.6
1.62
449
2243
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
479
2509
3.52
60.31
4.5
3.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
371
1804
3.09
50.25
3.8
2.1
mmol/l
2.4
2.4
2.21
346
1484
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
478
2839
2.89
42.25
7.1
3.9
umol/l
10.2
12.2
5.68
459
2668
(3033658) Prothrombin time (PT) actual/Normal
292
1354
2.89
41.37
5.4
3.5
%
87.0
85.7
0.37
287
1316
(3032080) INR in Blood by Coagulation assay
434
2473
2.79
41.20
7.0
10.3
inr
1.1
1.3
4.78
118
691
(3023368) Bacteria identified in Blood by Culture
311
1541
2.74
38.17
4.8
4.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
178
672
3.16
35.82
1.8
1.8
%
1.9
1.6
2.65
163
576
(3007853) Bacteria identified in Skin by Aerobe culture
177
667
3.16
35.72
1.9
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
200
844
2.87
32.70
2.1
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
479
3093
2.52
31.85
9.5
6.5
e9/l
4.4
4.3
0.17
426
2683
(3000494) Fungus identified in Specimen by Culture
175
703
2.94
31.19
1.7
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
521
3521
2.57
31.02
7.3
4.3
mmol/l
6.6
6.8
2.47
509
3293
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
421
2600
2.41
30.36
8.1
5.0
mmol/l
1.2
1.2
2.73
397
2296
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
166
708
2.73
26.03
9.4
6.6
kpa
5.4
5.1
3.29
159
684
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
438
2869
2.27
25.97
8.9
5.4
mmol/l
1.2
1.2
3.81
376
2426
(3027801) Oxygen [Partial pressure] in Arterial blood
165
708
2.71
25.52
9.5
6.6
kpa
13.3
11.5
4.25
159
685
(3003694) ABO and Rh group [Type] in Blood
264
1413
2.34
25.38
1.6
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
164
707
2.69
25.10
9.5
6.6
mmol/l
1.5
1.5
0.01
139
546
(40758558) Short blood count panel - Blood
245
1289
2.34
24.33
8.1
4.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
309
1796
2.23
24.11
2.8
2.7
u/l
34.2
35.7
0.19
298
1705
(3018418) pH of Serum or Plasma
287
1623
2.24
23.92
4.4
3.0
ph
7.4
7.4
0.61
57
268
(3014111) Lactate [Moles/volume] in Serum or Plasma
128
504
2.86
23.20
9.2
5.8
mmol/l
1.2
1.4
2.17
121
486
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
583
4420
2.43
22.86
9.2
5.4
u/l
80.0
75.4
1.73
569
4086
(3000991) Gas panel - Venous blood
122
481
2.83
22.00
10.4
6.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
138
600
2.59
20.46
2.0
2.3
umol/l
10.0
8.8
0.15
127
522
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
87
298
3.17
20.06
3.6
1.5
ug/l
5.9
3.9
0.67
79
229
(3006315) Basophils [#/volume] in Blood
406
2782
2.00
19.04
5.7
5.5
e9/l
0.0
0.0
0.78
350
2403
(3001604) Monocytes [#/volume] in Blood
403
2768
1.99
18.62
5.7
5.5
e9/l
0.6
0.6
0.62
347
2382
(42870588) Differential panel, method unspecified - Blood
296
1835
2.01
18.27
5.5
5.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
381
2579
1.97
18.24
5.9
5.8
%
2.7
3.0
1.26
366
2388
(3019069) Monocytes/100 leukocytes in Blood
382
2591
1.97
18.15
6.1
6.0
%
9.0
8.8
0.49
368
2409
(3022096) Basophils/100 leukocytes in Blood
370
2495
1.95
17.75
5.9
5.7
%
0.6
0.7
2.63
355
2311
(3013115) Eosinophils [#/volume] in Blood
412
2885
1.95
17.63
5.8
5.7
e9/l
0.2
0.2
0.60
360
2523
(3019198) Lymphocytes [#/volume] in Blood
405
2834
1.93
17.21
5.7
5.6
e9/l
1.7
1.9
1.11
351
2489
(3002030) Lymphocytes/100 leukocytes in Blood
383
2640
1.92
16.94
6.0
5.9
%
23.0
27.5
10.26
368
2444
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
26
8.28
15.83
1.1
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
376
2620
1.87
15.67
5.8
5.7
%
61.3
57.5
6.35
361
2440
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
120
551
2.40
15.61
2.7
2.9
u/l
211.4
244.3
6.03
115
515
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
174
960
2.06
14.32
1.9
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
192
1102
2.00
14.13
2.9
2.5
mosm/kgh2o
525.7
552.5
0.90
164
926
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
79
312
2.71
14.01
9.7
9.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
267
1721
1.86
13.80
3.5
2.9
e6/l
116.7
110.9
0.03
211
1333
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
59
5.07
13.67
1.2
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
339
2362
1.79
13.48
2.5
2.2
nmol/l
77.0
77.4
0.08
315
2055
(3030467) Casts [#/volume] in Urine by Automated count
247
1576
1.85
13.05
3.3
2.9
e6/l
0.5
0.4
0.39
193
1186
(3021589) Normoblasts [#/volume] in Blood
351
2491
1.77
12.95
13.1
8.5
e9/l
0.0
0.0
0.37
280
2041
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
86
370
2.50
12.81
1.9
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
239
1518
1.84
12.76
3.3
2.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
104
492
2.29
12.53
3.1
2.3
ml/min/173m2
69.1
65.1
0.41
44
193
(3004789) Transferrin [Mass/volume] in Serum or Plasma
145
784
2.05
12.46
2.5
2.3
g/l
2.2
2.3
0.74
131
718
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
137
728
2.08
12.33
2.7
2.4
%
21.3
23.8
1.00
118
616
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
374
2.44
12.05
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
300
2067
1.75
12.03
3.4
2.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
1050
1.91
11.86
3.4
2.1
mmol/l
2.5
2.4
4.91
160
899
(3023199) Leukocytes [#/volume] in Pleural fluid
25
52
4.94
11.50
1.6
1.3
e6/l
4708.4
2164.5
0.26
16
37
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
48
162
3.10
11.31
2.5
2.9
u/ml
0.3
0.4
0.28
26
95
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
112
572
2.13
11.13
4.4
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
86
396
2.32
11.00
1.7
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
476
3780
1.71
10.95
3.6
3.0
u/l
58.2
49.6
1.29
452
3484
(3022948) Iron [Moles/volume] in Serum or Plasma
153
881
1.93
10.88
2.5
2.3
umol/l
11.5
13.3
2.09
142
800
(3018095) Leukocytes [#/volume] in Urine
287
2002
1.70
10.70
4.1
3.4
e6/l
58.8
106.5
1.09
217
1428
(3035637) Corticotropin [Mass/volume] in Plasma
22
44
5.12
10.57
1.5
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
45
5.01
10.31
1.7
1.3
e6/l
27013.1
139674.1
0.43
11
28
(3000850) Epithelial cells [#/volume] in Urine
190
1192
1.80
10.24
2.7
2.3
e6/l
6.4
5.7
0.22
166
1042
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
154
916
1.86
9.84
3.0
2.7
e6/l
2.6
2.2
0.17
84
496
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
108
574
2.03
9.60
1.9
3.2
ng/l
244.7
221.6
0.17
99
534
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
220
1463
1.71
9.58
2.2
2.2
mg/l
2.7
3.0
1.88
194
1223
(3003434) Protein [Mass/volume] in Pleural fluid
24
58
4.24
9.23
1.5
1.3
g/l
33.5
25.7
1.55
19
50
(40768800) Prostate Pathology biopsy report
21
46
4.67
9.11
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
145
2.93
8.94
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
274
1959
1.63
8.91
2.7
3.1
ng/l
1113.9
1428.0
0.96
248
1667
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
660
5908
1.98
8.53
25.2
12.8
mg/l
34.3
24.0
9.29
598
4572
(3045788) Cell count panel - Pleural fluid
19
42
4.62
8.16
1.7
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
91
482
2.01
8.14
2.7
2.1
u/l
41.6
35.9
0.24
79
396
(3003181) Sodium [Moles/volume] in Urine
32
106
3.11
7.82
1.5
1.3
mmol/l
57.8
64.3
0.31
24
87
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
34
121
2.90
7.36
2.8
2.0
u/ml
19.2
110.3
0.76
29
97
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
14
26
5.47
7.27
3.9
1.8
nmol/l
2.2
3.2
0.56
14
26
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
101
3.05
7.15
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
518
4420
1.56
7.08
4.5
3.6
pmol/l
14.7
15.0
1.10
470
3976
(3051651) Icteric interference index of Serum or Plasma
14
27
5.26
6.99
5.6
3.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
114
684
1.79
6.95
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
114
684
1.79
6.95
1.9
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
304
2333
1.51
6.79
2.9
2.6
ug/l
154.2
140.5
0.47
282
2120
(40768806) Pleura Pathology biopsy report
17
40
4.33
6.78
1.8
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
515
4412
1.53
6.70
3.8
4.0
mm/h
15.2
12.1
3.96
480
4046
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
542
6022
0.64
6.58
4.4
4.7
mmol/l
1.5
1.4
1.13
491
5503
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
566
6211
0.64
6.15
5.0
5.3
mmol/l
2.5
2.7
3.50
516
5690
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
215
2.27
6.14
1.7
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
112
693
1.72
6.12
1.8
2.0
%
1.8
1.8
0.05
100
613
(3044889) 12 lead EKG panel
506
4358
1.50
6.08
4.4
4.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
144
2071
0.62
6.05
2.8
3.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
23
5.29
6.02
1.6
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
23
5.29
6.02
1.6
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
552
6081
0.65
5.96
4.5
4.7
mmol/l
4.5
4.6
1.48
502
5583
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
148
992
1.61
5.95
2.8
2.5
e6/l
1.0
1.5
0.57
80
569
(3031040) Bacteria [#/volume] in Urine by Automated count
448
3776
1.46
5.94
4.6
4.3
e6/l
2519.0
2165.4
—
6
59
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
36
4.23
5.84
1.3
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
44
200
2.27
5.84
3.0
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
233
2.18
5.84
1.9
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
45
3.84
5.84
1.8
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
88
515
1.80
5.82
3.6
1.9
nmol/l
412.4
359.1
1.39
83
471
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
48
227
2.19
5.80
1.9
1.8
ug/l
2.0
1.8
0.12
39
200
(3021960) Folate [Moles/volume] in Serum or Plasma
213
1560
1.51
5.77
1.6
1.5
nmol/l
20.8
21.0
0.06
188
1302
(3019309) Folate [Moles/volume] in Red Blood Cells
176
1239
1.55
5.72
1.8
1.8
nmol/l
1129.1
1170.8
0.24
125
934
(3019060) Gas panel - Arterial blood
75
424
1.85
5.54
6.2
5.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
50
246
2.11
5.48
1.5
1.6
g/l
1.6
1.5
0.29
43
210
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
34
4.18
5.38
1.6
1.4
u/l
45.0
28.5
0.71
14
22
(3023183) Ammonium ion [Moles/volume] in Plasma
33
138
2.46
5.29
1.9
2.9
umol/l
35.3
35.0
0.02
25
119
(3010503) CD19 cells [#/volume] in Blood
11
22
5.06
5.27
1.7
1.7
e9/l
0.1
0.2
0.76
11
22
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
172
1227
1.52
5.21
4.4
4.0
ng/l
488.8
372.6
0.16
149
1019
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
238
1831
1.44
4.90
3.1
2.3
u/l
50.4
57.4
2.45
227
1688
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
52
3.32
4.77
1.7
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
29
4.19
4.64
1.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
53
3.26
4.64
5.5
3.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
28
116
2.47
4.60
3.1
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
11
25
4.45
4.57
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
99
2.58
4.50
2.0
2.8
e9/l
4.4
4.6
0.11
25
99
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
39
3.64
4.50
1.9
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
127
879
1.54
4.39
19.7
26.2
inr
1.3
1.3
0.02
18
123
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
102
2.50
4.25
2.0
3.1
%
62.4
59.2
0.57
25
102
(3020630) Protein [Mass/volume] in Serum or Plasma
75
463
1.69
4.14
2.3
1.5
g/l
65.7
67.4
0.85
69
414
(3012501) Base excess in Blood by calculation
27
116
2.38
4.13
4.0
3.6
mmol/l
2.9
2.9
0.02
18
76
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
320
2657
1.36
4.01
2.1
2.0
pmol/l
92.9
94.8
0.29
172
1347
(3052851) Hemolysis interference index of Serum or Plasma
34
164
2.12
3.98
5.5
3.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
82
2.61
3.91
1.9
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
11
7.34
3.86
1.9
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
536
5820
0.72
3.77
4.1
4.2
mmol/l
1.3
1.3
0.10
491
5284
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
111
2.30
3.58
1.5
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
532
4816
1.36
3.56
29.8
15.5
%
13.9
13.7
3.61
522
4684
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
26
3.88
3.53
1.8
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
69
2.65
3.49
1.7
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
64
2.69
3.41
2.0
2.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
95
2.36
3.36
1.8
1.2
—
—
—
0
0
(4010399)
71
458
1.61
3.34
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
562
6026
0.73
3.29
4.6
4.8
mmol/l
6.1
6.1
0.17
507
5448
(3026008) Bacteria identified in Urine by Culture
214
1714
1.35
3.27
3.0
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
453
4035
1.31
3.21
4.2
4.1
—
—
—
0
0
(3000492) Spirometry study
79
528
1.55
3.20
1.4
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
14
49
2.89
3.20
1.3
1.3
promille
2.0
1.3
—
9
39
(3016228) CD19 cells/100 cells in Blood
8
15
5.38
3.19
1.9
1.5
%
7.6
6.9
—
8
15
(21494814) CD8 cells/100 lymphocytes in Specimen
8
15
5.38
3.19
1.9
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
607
5651
1.39
3.11
23.6
11.7
ml/min/173m2
82.8
77.9
6.82
535
4568
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
368
3206
1.29
3.00
2.4
2.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
85
587
1.51
2.98
3.6
3.0
mmol/l
3.1
2.3
1.04
72
471
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
40
3.03
2.98
1.3
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
79
0.00
2.95
0.0
1.3
—
8.0
—
0
57
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
171
1.91
2.90
3.2
1.3
mg/l
42.5
42.3
0.01
27
140
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
172
1.90
2.85
3.2
1.3
mg/l
25.0
30.8
1.11
27
142
(1616796) Gas panel - Central venous blood
24
117
2.09
2.80
3.2
3.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
239
1985
1.30
2.76
2.3
2.2
u/l
240.2
260.3
0.09
228
1860
(40767503) Oxygen content in Capillary blood by calculation
24
118
2.07
2.74
2.8
2.6
%
16.6
16.6
—
9
64
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
14
5.04
2.73
2.6
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
663
6301
1.45
2.72
28.7
15.6
mmol/l
138.5
139.8
20.44
654
6125
(3023520) Reticulocytes [#/volume] in Blood
75
520
1.49
2.60
1.8
2.2
e9/l
68.8
70.3
0.12
56
407
(40768795) Lymph node Pathology biopsy report
7
15
4.70
2.60
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
75
2.30
2.52
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
16
4.41
2.48
2.7
4.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
663
6323
1.42
2.45
28.7
15.6
mmol/l
4.0
4.0
2.86
652
6134
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
117
2.00
2.42
1.8
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1235
1.32
2.40
1.5
1.7
mg/l
1.3
1.1
0.49
121
949
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
112
1.99
2.32
1.8
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
287
2483
1.25
2.31
4.0
3.9
ng/l
34.6
72.4
1.13
226
1823
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
580
5443
1.29
2.23
5.6
4.4
mu/l
2.4
2.2
0.35
537
4915
(3019230) Fractional oxyhemoglobin in Venous blood
22
115
1.94
2.17
1.5
2.2
%
57.4
62.3
0.37
22
115
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
68
940
0.70
2.17
1.3
1.3
u/ml
11.5
12.4
0.05
30
351
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
408
0.55
2.16
2.7
2.5
—
19.9
—
0
17
(3017143) Hepatitis C virus Ab [Presence] in Serum
70
500
1.44
2.12
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
75
545
1.42
2.07
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
650
6212
1.35
2.07
21.8
12.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
15
4.02
2.04
1.8
2.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
15
4.02
2.04
2.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
140
1.81
2.03
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
170
1.73
2.03
1.5
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
35
217
1.64
2.00
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
305
1.54
2.00
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
139
1699
0.78
1.95
1.6
1.6
mmol/l
1.2
1.4
2.39
119
1410
(3025159) Blasts/100 leukocytes in Blood
56
390
1.47
1.95
3.6
4.5
%
0.0
1.1
0.50
15
80
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
11
4.57
1.94
1.2
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
451
1.43
1.90
4.3
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
65
2.18
1.89
1.6
1.1
—
—
—
0
0
(4062490)
12
52
2.33
1.88
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
144
1.76
1.87
1.5
2.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
47
319
1.51
1.86
1.1
1.2
iu/ml
106.7
146.1
0.55
19
126
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
66
2.14
1.83
1.6
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
66
2.14
1.83
1.6
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
73
2.08
1.81
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
57
405
1.44
1.80
3.6
4.4
%
0.1
0.0
0.42
16
88
(3019225) pH of Specimen
78
586
1.37
1.80
4.5
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
59
423
1.43
1.78
3.5
4.3
%
1.1
0.7
0.71
17
95
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
67
2.11
1.77
1.6
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
67
2.11
1.77
1.6
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
67
2.11
1.77
1.6
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
76
571
1.37
1.76
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
41
2.46
1.76
1.9
4.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
186
2172
0.81
1.74
4.2
4.0
mg/mmol
10.7
7.7
0.58
117
1379
(3015235) Bicarbonate [Moles/volume] in Capillary blood
27
163
1.68
1.73
2.8
2.8
mmol/l
25.6
25.1
0.19
22
145
(40768441) Liver Pathology biopsy report
8
30
2.68
1.72
1.1
1.3
—
—
—
0
0
(4281824)
8
30
2.68
1.72
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
111
1.82
1.70
2.8
2.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
77
998
0.75
1.67
1.3
1.3
iu/ml
26.1
34.8
0.41
20
309
(3034426) Prothrombin time (PT)
6
19
3.17
1.66
1.0
1.4
—
—
—
0
0
(3020891) Body temperature
40
270
1.51
1.64
6.5
4.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
92
1.87
1.57
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
53
383
1.41
1.56
3.5
4.4
%
1.0
0.3
1.35
12
75
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
123
1.73
1.52
1.5
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
21
2.87
1.51
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
12
229
0.52
1.49
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
85
668
1.31
1.48
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
124
1.71
1.48
1.5
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
54
397
1.39
1.45
2.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
80
1.89
1.45
1.5
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
88
1.84
1.42
1.9
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
89
712
1.28
1.37
1.2
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
23
2.62
1.37
1.8
1.3
u/l
211.7
207.7
—
6
23
(3045424) Erythrocytes [Presence] in Urine
15
82
1.85
1.36
1.7
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
646
0.73
1.36
1.6
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
41
0.00
1.31
0.0
1.1
—
2.2
—
0
9
(40768797) Stomach Pathology biopsy report
98
799
1.26
1.30
1.5
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
175
0.51
1.30
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
660
6397
1.26
1.30
13.0
9.1
u/l
25.7
26.8
0.88
641
6125
(3013512) EKG study
212
1871
1.19
1.29
4.1
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
446
0.68
1.29
1.7
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
18
2.79
1.28
1.4
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
35
2.30
1.27
2.0
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
181
2058
0.84
1.24
3.4
3.3
mg/l
64.5
198.4
1.29
116
1307
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.21
1.8
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.21
1.8
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
26
2.32
1.19
1.5
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
21
133
1.60
1.18
3.2
1.5
u/ml
28.9
26.3
0.07
21
127
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
1.6
1.2
umol/l
25.0
29.1
—
5
20
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
95
1.70
1.14
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
119
1.61
1.12
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
119
1.61
1.12
1.5
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
51
1.97
1.11
2.4
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
193
1.47
1.10
2.5
2.4
g/l
0.2
0.2
0.20
19
62
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.8
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
190
2130
0.86
1.09
3.6
3.2
mmol/l
6.5
7.9
4.08
155
1778
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
191
2140
0.86
1.08
4.2
3.6
%
19.1
23.5
3.26
85
971
(3009343) pH of Capillary blood
52
401
1.32
1.08
3.4
3.3
ph
7.4
7.4
—
6
50
(3006184) Hemoglobin [Mass/volume] in Capillary blood
22
145
1.53
1.07
2.5
2.1
g/l
132.7
133.1
0.03
14
110
(3009542) Hematocrit [Volume Fraction] of Blood
553
5305
1.16
1.04
25.8
14.1
%
37.6
40.2
9.90
396
3557
(4268621)
9
48
1.89
1.00
1.9
2.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
148
1.50
0.99
1.4
1.3
ug/g
252.1
298.1
0.59
16
87
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
84
1.68
0.98
1.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
2.2
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
2.2
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
2.2
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
2.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
30
0.00
0.97
0.0
1.3
—
6.8
—
0
30
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
304
0.68
0.95
1.3
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
561
5806
0.87
0.94
6.0
6.3
mmol/mol
39.3
40.5
2.39
527
5374
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
62
1.79
0.94
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
49
384
1.30
0.93
3.5
2.9
e9/l
3.8
4.2
0.68
38
285
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
42
322
1.32
0.93
2.3
2.4
%
1.4
1.2
0.57
42
322
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
29
2.08
0.89
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
29
2.08
0.89
1.5
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
29
2.08
0.89
2.8
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
669
1.22
0.89
2.3
2.6
ug/l
5.9
7.7
0.66
72
587
(3003338) MCHC [Mass/volume]
521
5000
1.14
0.89
29.2
17.0
g/l
332.2
333.0
1.21
515
4966
(3026493) Urate [Moles/volume] in Serum or Plasma
143
1613
0.86
0.88
2.8
2.4
umol/l
9359.0
7257.2
0.16
120
1376
(3005719) IgG [Mass/volume] in Serum or Plasma
49
389
1.28
0.86
2.8
2.3
g/l
10.7
11.0
0.22
43
356
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
72
1.68
0.85
1.3
2.0
pg
32.8
33.2
0.15
12
72
(3028707) Methadone [Presence] in Urine by Screen method
10
57
1.76
0.84
4.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
38
293
1.31
0.83
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.82
1.6
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
216
1.36
0.80
2.7
1.3
g/l
3.3
3.1
0.47
22
168
(3015183) Erythrocyte sedimentation rate
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
90
1.57
0.78
6.4
2.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
387
1.26
0.76
3.5
3.3
mmol/l
2.8
2.0
0.96
39
293
(3035320) C reactive protein [Mass/volume] in Body fluid
7
38
1.85
0.73
1.3
2.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
25
2.01
0.72
1.4
1.8
e9/l
0.2
0.2
—
5
20
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
25
2.01
0.72
1.4
1.8
e6/l
852.2
492.3
—
5
20
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
39
1.80
0.72
1.3
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
39
1.80
0.72
1.4
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
363
0.76
0.69
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
61
1.65
0.68
3.0
4.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
42
1.67
0.68
1.1
1.5
—
322.0
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
1.4
1.4
g/l
1.1
1.0
—
7
42
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
119
1.44
0.67
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
44
1.60
0.65
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
31
244
1.28
0.62
1.8
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
130
1.39
0.61
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
218
1.30
0.61
2.8
1.3
g/l
11.2
10.9
0.10
23
185
(3000330) Specific gravity of Urine by Test strip
25
322
0.77
0.60
2.4
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
308
2913
1.10
0.60
3.5
3.6
estimate
0.0
0.0
0.00
68
467
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.2
—
0.7
—
0
11
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.8
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
106
1.42
0.58
1.1
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
35
1.72
0.57
1.3
1.3
nmol/l
114.7
152.7
—
6
35
(3051593) INR in Capillary blood by Coagulation assay
6
35
1.72
0.57
1.2
16.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
115
1.40
0.57
3.2
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
71
810
0.86
0.54
4.3
4.8
%
35.5
32.0
1.42
51
527
(3014271) Vancomycin [Susceptibility]
6
38
1.58
0.54
3.2
2.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
9
63
1.43
0.52
1.6
1.3
pmol/l
76.7
60.5
—
9
63
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
63
1.43
0.52
1.3
1.8
u/ml
2.3
67.1
—
9
58
(3011288) Drugs identified in Urine by Screen method
12
83
1.45
0.52
4.0
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
40
1.50
0.51
1.0
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
250
2645
0.92
0.51
4.6
3.8
ug/l
2.2
2.0
0.25
217
2378
(4094501)
13
179
0.72
0.50
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
234
1.25
0.50
2.8
1.3
g/l
4.4
4.0
0.50
23
165
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
234
1.25
0.50
2.8
1.3
g/l
7.5
7.5
0.08
23
171
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
234
1.25
0.50
2.8
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
345
0.80
0.50
2.2
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
67
1.50
0.50
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
107
0.65
0.49
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
119
1.35
0.48
3.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
85
1.42
0.47
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
301
2873
1.08
0.46
4.4
4.8
estimate
0.0
0.0
0.00
70
483
(3021788) Differential panel - Synovial fluid
8
118
0.67
0.46
1.6
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
50
1.40
0.45
4.7
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
128
1178
1.10
0.45
4.3
4.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
121
1.33
0.44
3.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
121
1.33
0.44
3.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
125
1356
0.91
0.44
3.5
3.9
kg/l
1.0
1.0
0.55
13
196
(3029937) Albumin [Presence] in Urine by Test strip
166
1550
1.09
0.43
4.1
3.8
estimate
0.0
0.0
0.50
64
469
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
78
1.42
0.43
1.5
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.8
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
158
1.27
0.42
1.5
1.7
—
—
—
0
0
(4211845)
5
33
1.52
0.41
2.6
3.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
16
0.00
0.41
0.0
1.2
—
99.3
—
0
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
148
1380
1.09
0.40
3.1
3.6
—
—
—
0
0
(3004451) EKG impression Narrative
5
34
1.47
0.40
1.8
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
18
0.00
0.40
0.0
1.8
—
8.9
—
0
12
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
61
1.31
0.39
1.6
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
52
589
0.87
0.39
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
159
0.75
0.38
3.0
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
147
1374
1.09
0.38
1.6
1.7
pmol/l
74590628.1
22044878.0
0.31
122
1125
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
212
2232
0.93
0.38
3.8
3.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
451
1.14
0.36
3.2
3.5
ng/l
63.9
85.0
1.66
46
400
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
122
0.73
0.35
3.1
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
123
0.73
0.35
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
124
0.72
0.35
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
308
0.84
0.34
2.2
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
297
2861
1.06
0.34
3.5
3.6
estimate
0.0
0.0
0.00
67
485
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
2.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
2.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
2.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
191
1.21
0.33
1.3
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
253
0.83
0.33
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
87
0.69
0.33
2.8
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
294
1.16
0.33
3.9
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
90
830
1.10
0.32
8.3
7.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
52
1.35
0.31
1.3
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
131
0.76
0.31
1.3
1.1
—
10.8
—
0
10
(21494755) Public health laboratory ask at order entry panel
38
431
0.88
0.31
1.2
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
53
1.32
0.31
1.6
1.8
%
9.2
10.4
—
7
53
(3019832) Treponema pallidum Ab [Presence] in Serum
22
261
0.84
0.30
1.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
120
1.26
0.30
3.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
316
1.15
0.29
2.3
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
106
992
1.08
0.28
1.5
1.3
g/l
3.0
2.8
0.36
62
575
(3049717) Cytology report of Urine Cyto stain
24
205
1.18
0.27
2.9
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
143
1504
0.94
0.26
2.9
2.6
ug/l
0.7
0.7
0.02
92
990
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
77
1.30
0.26
1.1
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
74
1.22
0.25
1.1
1.3
nmol/l
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
169
0.83
0.24
1.1
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
70
751
0.93
0.22
1.3
1.3
titre
656.5
526.7
0.18
17
180
(3039443) Prostate specific Ag panel - Serum or Plasma
13
157
0.82
0.22
1.4
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
95
0.73
0.22
1.6
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
668
6628
1.07
0.21
34.6
18.9
e9/l
256.0
243.6
3.90
655
6425
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
11
0.00
0.21
0.0
1.5
—
7.6
—
0
5
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.4
—
0.5
—
0
11
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
24.1
—
0
10
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
98
1.23
0.21
3.9
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
2.0
—
0
12
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
668
6629
1.07
0.21
34.5
18.8
fl
92.2
91.4
4.75
660
6499
(3042733) HLA Ab [Presence] in Serum
0
13
0.00
0.21
0.0
4.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
17
145
1.18
0.20
1.4
2.2
mg/l
10.2
12.8
1.24
17
135
(3035941) MCH [Entitic mass]
668
6630
1.07
0.20
34.5
18.8
pg
30.7
30.5
2.51
660
6500
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
668
6631
1.07
0.20
34.6
18.9
e12/l
4.2
4.5
41.20
653
6407
(3010813) Leukocytes [#/volume] in Blood
668
6632
1.07
0.19
34.7
18.9
e9/l
7.1
6.7
2.30
654
6411
(4024509)
6
51
1.18
0.19
1.2
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
48
519
0.92
0.19
3.8
3.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
668
6633
1.06
0.19
34.8
19.0
g/l
127.4
137.4
42.51
662
6502
(4034850)
19
217
0.87
0.18
16.1
10.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
60
1.17
0.18
1.1
1.7
—
—
—
0
0
(4306422)
10
82
1.22
0.17
1.1
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
129
1.17
0.17
1.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
68
0.73
0.17
1.0
1.1
—
21.9
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
30
329
0.91
0.16
2.9
2.7
mmol/l
27.2
25.4
1.74
30
322
(3048689) Calprotectin [Mass/mass] in Stool
55
585
0.94
0.15
2.4
2.3
ug/g
408.0
135.0
0.90
45
472
(3044927) Protein electrophoresis panel - Urine
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
78
1.16
0.15
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
192
0.88
0.15
2.5
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
89
0.78
0.14
2.6
2.3
mmol/l
101.0
105.2
—
7
89
(3041354) Potassium [Moles/volume] in Venous blood
7
89
0.78
0.14
2.6
2.3
mmol/l
3.7
4.1
—
7
89
(3044290) Cell count panel - Cerebral spinal fluid
13
112
1.16
0.14
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
106
0.85
0.13
1.6
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
116
0.86
0.12
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
167
0.90
0.11
3.0
4.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
177
0.90
0.10
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
96
1.15
0.10
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
126
1.11
0.09
1.1
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
243
1.07
0.09
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
39
410
0.95
0.08
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
1.1
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
16
147
1.09
0.07
1.7
1.8
pmol/l
219.4
217.8
0.03
16
137
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
87
1.03
0.07
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
100
0.90
0.06
2.9
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
335
0.95
0.06
1.2
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
90
1.11
0.05
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
43
444
0.97
0.05
2.0
2.3
nmol/l
12.9
14.7
0.74
35
396
(42529406) Shigella sp [Presence] in Stool by Culture
17
181
0.94
0.05
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
112
1138
0.98
0.04
1.3
1.2
u/ml
1.5
1.5
0.03
30
320
(3041096) Erythrocytes [Presence] in Urine by Automated
150
1517
0.99
0.04
3.5
3.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
311
0.96
0.03
3.4
3.2
%
48.4
48.2
0.01
30
306
(3022621) pH of Urine by Test strip
39
401
0.97
0.03
2.3
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
92
1.09
0.03
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
178
0.95
0.02
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
176
0.97
0.00
1.8
1.6
g/l
1.2
1.2
0.56
17
168
(3014051) Protein [Presence] in Urine by Test strip
14
135
1.04
0.00
1.8
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
185
0.97
0.00
1.8
2.4
ug/min
36.7
75.2
0.70
11
113
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
177
1.02
0.00
1.4
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
20
198
1.01
0.00
1.5
1.8
nmol/l
39.6
40.8
0.10
20
188
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
17
171
0.99
0.00
1.8
1.6
g/l
0.3
0.2
0.27
17
164
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.4
1.0
—
2.6
—
0
23
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.0
—
0
6
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.7
—
0
5
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
2.0
—
0
5
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
77
0.91
0.00
5.6
4.2
mmol/l
5.1
7.6
—
7
62
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
79
1.01
0.00
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
18.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
109.9
—
0
9
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
2.7
—
6.9
—
0
7
(4146454)
8
80
1.00
0.00
4.0
2.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TONGUENAS_EXALLC – Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).